CommentaryNon-alcoholic steatohepatitis: another disease of affluence
References (15)
- et al.
Profile of an urban hospital-based practice
Hepatology
(1996) - et al.
Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance
J Hepatol
(1998) - et al.
Nonalcoholic steatohepatitis: an expanded clinical entity
Gastroenterology
(1994) - et al.
The natural history of non-alcoholic fatty liver: a follow up study
Hepatology
(1995) - et al.
Steatohepatitis: a tale of two “hits”?
Gastroenterology
(1998) - et al.
Nonalcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease
Mayo Clin Proc
(1980) - et al.
Patient characteristics predicting cirrhosis and death in non-alcoholic steatohepatitis
Hepatology
(1998)
There are more references available in the full text version of this article.
Cited by (272)
Death by lipids: The role of small nucleolar RNAs in metabolic stress
2020, Journal of Biological ChemistryHepatic mast cell concentration directly correlates to stage of fibrosis in NASH
2019, Human PathologyInvolvement of orexin in lipid accumulation in the liver
2018, Journal of Oral BiosciencesThe Metabolic Syndrome, Oxidative Stress, and the Liver
2017, Liver Pathophysiology: Therapies and AntioxidantsNeonatal intake of oleanolic acid attenuates the subsequent development of high fructose diet-induced non-alcoholic fatty liver disease in rats
2018, Journal of Developmental Origins of Health and Disease
Copyright © 1999 Elsevier Ltd. All rights reserved.